1 Flashcards
Alemtuzumab
Recombinant humanised monoclonal antibody
Anti-CD52
CD52 is found on most B cells, T cells, monocytes, macrophages and some granulocytes
Rx: CLL, multiple sclerosis
Caution: may cause transient and severe hypotension caution with IHD
May cause hypotension, infusion related reactions, profound lymphopenia, pancytopenia
Bevacizumab
Recombinant humanised
binds to VEGF inhibiting angiogenesis
Risk of heart failure
Hypertension, impaired wound healing, thromboembolic events,
Blinatumomab
Recombinant, bispecific mAb
Binds to CD19 (B cells ) and CD3 (T cells)
Forms link that results in activation of T cells and the elimination of CD-19 positive B cells
Indicated: B cell ALL
Cytokine release syndrome, neurological toxicity, infection
Brentuximab vedotin
Conjugte - toxic payload: chimeric antibody (CD30) + monomethyl auristatin E (MMAE) a microtubule poison > cell cycle arrest and apoptosis
Containdicated with bleomycin
Renal avoid: <30mL/min
Hepatic avoid: Child B and C
Peripheral neuropathy, infusion related, PML, pneumonitis
Cetuximab
Recombinant chimeric Binds to EGFR inhibits proliferation, Skin reactions: acne, rash, infusion reaction, VTE, mucositis,
EGFR inhibitors
Cetuximab Panitumumab Afatinib Erlotinib Gefitinib
EGFR inhibitor skin reactions
Papulopustular rash
Face and upper body
Occurrence/severity may be associated with response to treatment
Rx doxycycline prophylaxis and steroids
Other skin signs: itch, dry skin, fissures, paronychia, nail disorders, abnormal hair growth
Ipilimumab
Human monoclonal Ab
CTLA-4 (cytotoxic T lymphocyte-associated antigen 4
CYP450 inducers
SCRAP GPS St. John's Wort Carbamazipine Rifampicin Alcohol (chronic) Phenytoin Griseofulvin Phenobarbital Sulphonylureas
CYP450 inhibitors
SICKFACES.COM GQ Sodium valproate Isoniazid Cimetidine Ketoconazole Fluconazole Alcohol (acute)/amiodarone Chloramphenicol Erythromycin Sulphonamides Ciprofloxicin Omeprazole Metronidazole Grapefruit juice Quinidine
Omalizumab
Recombinant humanised
Monoclonal antibody against IgE
Reduces the immune systems response to allergen exposure
Rx: asthma, chronic spontaneous urticaria
Thrombocytopenia, ? association with Churg-Strass syndrome
SE: injection site reactions, bleeding, headache, MSS pain, anaphylaxis , serum sickness-like reaction
Anti-CD20 antibodies
Rituximab
Ofatumumab
Obinutuzumab
Basilixumab
Chimeric monoclonal antibody against IL-2
Blocks IL-2 inhibiting T-lymphocyte proliferation
Rx: prevention of acute renal transplant rejection (also liver and lung)
Caution if previous Rx with basilixumab, may increase risk of hypersensitivity; ?increase in surgical wound complications
SE: hypersensitivity, cytokine release syndrome
Crizotinib
Tyrosine kinase inhibitor
Inhibits anaplastic lymphoma kinase (ALK) and hepatocyte growth factor (HGFR, c-Met)
Rx: anaplastic lymphoma (AKL +); non-small cell lung cancer (ALK+)
Afatinib
TKI
EGFR
HER2, HER4